RS Neuromarkers Updates

📅 Kick-off (done)

Kick-off to review our project RS Neuromarkers (June,2, 2025).

📅 Study initiation package (done)

We are organizing a clinical trial to collect real-world data, which will enable us to refine our algorithms and develop our biomarkers. We finalized our dossier (protocol, consent form, insurance, organization with the hospital, etc).

📅 SCULPT Clinical Trial (ongoing)

We launched our clinical trial at CHU Montpellier in October 2025. The objective is to compare bedside perfusion measurements from our SYLVER ultrasound system with CT perfusion (RapidAI) in neuro‑ICU patients, to validate SYLVER’s perfusion metrics and build the clinical dataset that will power future RS‑USP and RS‑LVO biomarkers.

📅 Tech development of RS-USP and RS-LVO (ongoing)

We are currently developing the two biomarkers: for RS-USP, the focus is on precise segmentation of hypoperfused areas by improving deconvolution algorithms and establishing sensitivity thresholds and for RS-LVO, the aim is to enhance vascular occlusion detection with high sensitivity for M1 occlusions and for distal segments and ACA/PCA.